Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
作者： Karsten Buschard , Pam Fredman
DOI:
关键词:
摘要: The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, specific catchers therefor (antibodies or lectins), monoclonal antibodies, for the prophylaxis therapy prediabetes, diabetes and/or associated complications an individual production pharmaceutical preparations treatment said conditions is disclosed.
google.it 参考文章(5)
Miguel A.Gama Sosa, Rita De Gasperi, Stefania Battistini, Mark P. Gorman, Robin Kolodny, Edwin H. Kolodny, A Human Kidney cDNA Which Induces a Cell Surface Protein Epitope Recognized by a Monoclonal Antibody against Galactosylceramide Biochemical and Biophysical Research Communications. ,vol. 227, pp. 636- 641 ,(1996) , 10.1006/BBRC.1996.1557
Victor Ginsburg, Victor E. Jimenez, Howard C. Krivan, Receptor for pathogenic fungi ,(1990)
Karsten Buschard, Jan-Eric Mansson, Pam Fredman, Novel glycolipid complexes and their uses ,(1997)
Alf Anton Lindberg, Karl-Anders Karlsson, A compound and a composition for therapeutic or diagnostic use and a process for therapeutic treatment ,(1984)